The direct impact of CagA on epithelial cells may facilitate the progression of cancer, as evidenced by the development of carcinomas in transgenic mice and zebrafish that have been genetically modified to produce CagA, even in the absence of inflammation. This evidence concerns the gene S100A8 and cancer.